Transient Ischaemic Attack
6
0
0
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
33%
2 trials in Phase 3/4
67%
2 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
THALES - Acute STroke or Transient IscHaemic Attack Treated With TicAgreLor and ASA for PrEvention of Stroke and Death
Psychoeducation for Transient Ischaemic Attack and Minor Stroke
Reactivation of Varicella Zoster Virus and Risk of Vascular Disease
Diagnosis by Comprehensive Cardiovascular Imaging for Stroke and TIA
Serum Uric Acid Levels and Onset of Cardiovascular Diseases: a CALIBER Study
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]